Clinical Trials Sponsored by Zambon SAU

Total 11124 results

Zambon SAU
Bioventus LLC

Completed

Durolane SJ for Treatment of Rhizarthrosis

Rhizarthrosis

Spain
Zambon SpA

Completed

A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa

Parkinson Disease

China
Zambon SpA

Enrolling by invitation

Extension Trial on Efficacy / Safety of L-CsA + SoC in Treating BOS in Post Single or Double Lung Transplant (BOSTON-3) (BOSTON-3)

Bronchiolitis Obliterans | Bronchiolitis Obliterans Syndrome | Obliterative Bronchiolitis

France, United States, Spain, Israel, Belgium, Denmark, Germany, United Kingdom, Austria
Zambon SpA

Terminated

A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis After Hematopoietic Transplant (BOSTON-4) (BOSTON-4)

Stem Cell Transplant Complications | GVHD, Chronic | Bronchiolitis Obliterans Syndrome (BOS)

Spain, France, Germany
Zambon SpA

Completed

Effect of Safinamide on Parkinson's Disease Related Chronic Pain

Idiopathic Parkinson Disease

Spain, Austria, Italy, Germany, France
Zambon SpA

Completed

A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

Respiratory Tract Diseases | Abnormal Mucus Secretions

China
Zambon SpA

Completed

Clinical Study to Evaluate Z7200 Pharmacokinetics Profile

Asthma

United Kingdom
Zambon SpA

Completed

Bioequivalence Study of Two Different Formulations of N-acetyl-cysteine (NAC)

no Condition
Zambon SpA

Completed

A Study to Evaluate Pharmacokinetics, Safety and Tolerability of Single and Multiple Intravenous Doses of N-acetylcysteine (NAC) in Chinese Healthy Volunteers

Respiratory Tract Disorders

China
Zambon SpA

Withdrawn

Safinamide for Levodopa-induced Dyskinesia (PD-LID)

Parkinson Disease | Dyskinesia, Drug-Induced
Zambon SpA

Terminated

Trial in Non-cystic Fibrosis Bronchiectasis Patients With Chronic Lung Infections Treated With Colistimethate Sodium. (PROMIS-II)

Non Cystic Fibrosis Bronchiectasis

United States, Argentina, Australia, Canada, France, Germany, Greece, Israel, Italy, New Zealand, Poland, Portugal
Zambon SpA

Completed

Efficacy and Safety of Inhaled CMS in Bronchiectasis Subjects With Chronic P. Aeruginosa Infection. (PROMIS-I) (PROMIS-I)

Non Cystic Fibrosis Bronchiectasis

Australia, Greece, Israel, Italy, Portugal, Belgium, Germany, Netherlands, New Zealand, Spain, Switzerland, United Kingdom
Zambon SpA

Active, not recruiting

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1) (BOSTON-1)

Bronchiolitis Obliterans | Lung Transplant Rejection | Lung Transplant; Complications | Lung Transplant Failure and Rejection | Chronic Rejection of Lung Transplant | Chronic Lung Allograft Dysfunction

France, United States, Spain, Israel, Belgium, United Kingdom, Germany
Zambon SpA

Completed

A Single and Multiple Dose Study to Assess How the Drug Enters, Moves Through and Exits the Body, Safety and Tolerability of Safinamide in Healthy Adult Chinese Volunteers

Healthy

China
Zambon SpA

Completed

A Clinical Study to Evaluate Z7200 (Budesonide/Formoterol) Pharmacokinetics Profile in Healthy Volunteers

Asthma

United Kingdom
Zambon SpA

Completed

Safinamide for Multiple System Atrophy (MSA)

Multiple System Atrophy

Italy, Spain
Zambon SpA

Completed

Study of the Effects of High-dose N-acetylcysteine (NAC) in Idiopathic Pulmonary Fibrosis (IPF) (IFIGENIA)

Pulmonary Fibrosis

Spain, Germany, Belgium, France, Italy, Netherlands, United Kingdom
Zambon SpA

Active, not recruiting

Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-2) (BOSTON-2)

Bronchiolitis Obliterans | Lung Transplant Rejection | Lung Transplant; Complications | Lung Transplant Failure and Rejection | Chronic Rejection of Lung Transplant | Chronic Lung Allograft Dysfunction

France, United States, Spain, Israel, Belgium, Denmark, Germany, United Kingdom, Austria
Zambon SpA

Completed

Phase 1 Three Part SAD, MAD & Cross-Over Study of ZP-059 in Healthy and Asthmatic Subjects

Allergic Bronchopulmonary Aspergillosis

United Kingdom
Zambon SpA

Completed

Efficacy and Tolerability Study of ZP-025 Vaginal Gel for the Treatment of Vaginal Dryness

Vaginal Dryness

Italy
Zambon SpA
FLUIDDA nv

Completed

Study to Compare the Effects of Z7200 And Symbicort® Turbohaler on Respiratory Imaging Parameters in Asthmatic Patients

Asthma | Asthma Chronic | Asthmatic | Asthma Bronchial

Belgium
Zambon SpA
Iqvia Pty Ltd

Completed

An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD (SUCCESS)

Parkinson's Disease

Spain, Italy, Germany
Cross Research S.A.
Zambon SpA

Completed

Safinamide Steady State Interaction With Rosuvastatin

Healthy

Switzerland
Cross Research S.A.
Zambon SpA

Completed

Riluzole Orodispersible Film Replicate Bioavailability

Bioequivalence

Switzerland
Zambon SpA
Cross Research S.A.

Completed

Drug Interaction Study of Safinamide and a BCRP Substrate, Diclofenac, Concomitantly Administered to Healthy Volunteers

Healthy

Switzerland
Ramon Oliveira

Terminated

Glycemic Control and Surgical Site Infection Incidence Among Liver Transplantation Recipients

Liver Transplantation | Surgical Wound Infection

Brazil
Samson NeuroSciences

Unknown

Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm

Aneurysmal Subarachnoid Hemorrhage | Cerebral Vasospasm

Germany, Czech Republic, Israel
University of Zambia
University Teaching Hospital, Lusaka, Zambia

Not yet recruiting

Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients (VMGMProtocol)

Diabetes Mellitus Type 2 Without Complication
Centre for Infectious Disease Research in Zambia
Ministry of Health, Zambia; University of Zambia

Withdrawn

The Zambia Ivermectin Trial for the Treatment and Prevention of COVID-19 (ZIT)

SARS-CoV-2 | Ivermectin

Zambia
Carbon Medical Technologies

Terminated

Injectable Bulking Agent Needle Guide (NG)

Urinary Incontinence | Intrinsic Sphincter Deficiency

United States
University of Zambia

Completed

Taenia Solium Control Case Study in Zambia (SANTOSOIL)

Helminthiasis | Cysticercosis

Zambia
Carbon Medical Technologies

Terminated

A Prospective, Multi-center, Randomized, Blinded Study to Evaluate Durasphere FI for the Treatment of Fecal Incontinence

Fecal Incontinence
Wake Forest University
Zambon SpA

Completed

Study of Expectorant Activity of Oral N-acetylcystein (NAC) in Patients With Stable Chronic Bronchitis

Chronic Bronchitis

United States
Derzhavin Tambov State University

Recruiting

Laser Treatment of Reticular Leg Veins vs. Sclerotherapy

Reticular Leg Veins

Russian Federation
Ospedale Pediatrico Bambin Gesù

Completed

Hemodynamic Impact of Cytosorb and CKRT in Children With Septic Shock (PedCyto)

Septic Shock

Italy
Derzhavin Tambov State University

Completed

Low Concentrate Detergents Versus Hypertonic Glucose for the Treatment of Telangiectasia

Sclerotherapy

Russian Federation
Ministry of Health, Zambia

Completed

Safety and Acceptability Study of PrePex Device When Removing the Foreskin Shortly After Placement of Device

HIV Prevention

Zambia
University Hospital, Clermont-Ferrand
Stryker SA; Polyclinique du Parc Rambot

Completed

Metaphyseal Distal Radius Fractures

Metaphyseal Radius Fractures (AO Type A2, A3, C1 et C2)

France
University Ramon Llull

Completed

Jaw Clenching on Anaerobic Ability and Ventilatory Flows

Mouth Breathing
PATH
Tulane University; Ministry of Health, Zambia; Macha Research Trust, Zambia

Active, not recruiting

Attractive Targeted Sugar Bait Phase III Trial in Zambia

Malaria | Malaria,Falciparum | Vector-Borne Transmission of Infection

Zambia
SAV-IOL SA
CEISO

Recruiting

Evaluation of Efficacy and Long-term Safety for Lucidis Instant Focus© - PMCF Study Protocol

Cataract

Switzerland
SAV-IOL SA
CEISO

Completed

Evaluation of Efficacy and Long-term Safety for the InFo - Instant Focus © Lens / PMCF (INFOLO)

Cataract
Mulungushi University
University of Zambia

Completed

Acute Salt Sensitivity of Blood Pressure (AcuteSS)

Blood Pressure

Zambia
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Patients With Multiple Sclerosis Disease (LOMBARD)

Multiple Sclerosis (MS) | Clinically Isolated Syndrome (CIS) | Secondary Progressive MS | Primary Progressive MS | Relapsing-Remitting MS

France, Spain, Switzerland
GeNeuro Innovation SAS

Completed

Longitudinal Therapeutically Non-interventional Study of MSRV-Env Burden in Normal Population (CONTROL)

Multiple Sclerosis

France
GeNeuro Innovation SAS

Completed

First-in-Human Study With GNbAC1 in Healthy Volunteers

Multiple Sclerosis
GeNeuro Innovation SAS

Completed

Safety Study of GNbAC1 Monoclonal Antibody in Healthy Male Volunteers

Healthy Volunteers

Germany
GeNeuro Innovation SAS

Completed

Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis (ProTEct-MS)

Multiple Sclerosis

Sweden
GeNeuro Innovation SAS

Completed

Safety Study of GNbAC1 in Multiple Sclerosis Patients

Multiple Sclerosis

Switzerland
Ospedale San Raffaele
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico; Ospedale Pediatrico...

Recruiting

Trikafta/Kaftrio and Pseudomonas Aeruginosa (Kaf-Pseudo)

Cystic Fibrosis

Italy

Clinical Trials Sponsored by Zambon SAU

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burkina Faso

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations